Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC in ME/CFS
NCT04542161Phase 2Active, not recruiting
- Sponsor
- Weill Cornell Medicine
- Start
- Sep 2020
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), sponsored by Weill Cornell Medicine. Started Sep 2020; status: active, not recruiting.
02
Drugs
acetylcysteine
03
Conditions
myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
Beyond the preview
Go deeper on NCT04542161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04542161.